Global Influenza Vaccine Market Report and Forecast from 2019 to 2024

Growing immunization for the prevention of influenza virus infection will increase the market growth in the future.

Global Influenza Vaccine Market

The international market of influenza vaccine is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.37% from $5.209 billion in the year 2018 to $7.547 billion by 2024. According to WHO, influenza vaccines strains are altered yearly for northern as well as southern hemisphere due to constant varying of circulating influenza viruses to more closely match currently circulating virus strains.

The expanding research and development expenditure and developments in vaccine technology are forcing the growth of the global influenza vaccine market in the forecast period. Additionally, growing immunization for influenza vaccine to prevent the viral infection will increase the market growth in the forthcoming years and beyond.

This research analyzes the current market trends with respect to demand, supply, and sales, in addition to the latest advancements. Major drivers, opportunities and restraints have been covered to provide a comprehensive picture of the market.

The analysis presents exhaustive information regarding the trends, development, and industry regulations and policies implemented in every geographical region. The regulatory framework of the market has been covered to offer investors a better understanding of the important factors affecting the market environment largely.

Recognizing the key industry players and their contribution to the overall business or relevant segment allied to the study have been covered as part of competitive intellect done through broad secondary research.

While conducting the secondary research, the diverse data and studies published by industry associations, investor presentations, analyst reports, journals and press releases among others have been taken into consideration.

To determine the size of the market and its key segments, both top-down and bottom-up approaches have been utilized. The obtained values are correlated with the primary inputs of the key investors in the worldwide influenza vaccination value chain.

The final step involves complete market engineering including analysis of data from existing proprietary databases and different sources while using several data triangulation methods for market forecasting and breakdown.

Analysis, charts, and graphics are the various forms in which the market intelligence is presented to help the clients in getting the insight of worldwide influenza vaccine market faster and efficiently.

GlaxoSmithKline plc., Seqirus, Sanofi Pasteur SA., Novavax, Inc., Emergent BioSolutions Inc. are major industry players among others. Through end-user, vaccine technology, and geography segments, the worldwide influenza vaccine market has been evaluated.